GH: Guardant Health, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 16,219.52
Enterprise Value ($M) 15,867.63
Book Value ($M) 1,298.49
Book Value / Share 12.93
Price / Book 14.66
NCAV ($M) 972.17
NCAV / Share 9.68
Price / NCAV 16.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.31

Liquidity (mrq)
Quick Ratio 27.93
Current Ratio 28.27

Balance Sheet (mrq) ($M)
Current Assets 1,888.36
Assets 2,271.78
Liabilities 916.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 286.73
Operating Income -254.95
Net Income -246.28
Earnings Per Share Basic And Diluted -2.60

Cash Flow Statement (mra) ($M)
Cash From Operations -103.93
Cash from Investing -617.09
Cash from Financing -617.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-11 13G/A Morgan Stanley 4.50 -10.55
02-10 13G Vanguard Group Inc 7.62
02-05 13G BlackRock Inc. 5.30
01-07 13G/A Eltoukhy Helmy 4.40 -6.55
10-13 13D/A Softbank Vision Fund (aiv M1) L.p. 7.10 -49.86
2020-02-14 13G/A Sequoia Capital U.s. Venture Fund Xiv, L.p. 2.50 -70.11
2020-02-13 13G/A Talasaz Amirali 4.80 0.00
2020-01-31 13G/A Khosla Ventures IV, L.P. 3.20 -58.57
2019-02-13 13G Sb Investment Advisers (uk) Ltd 30.10

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2021-02-25 10-K Annual Report – 10-K
2020-11-05 10-Q Quarterly Report – 10-Q
2020-08-06 10-Q Quarterly Report – 10-Q
2020-05-07 10-Q Quarterly Report – 10-Q
2020-03-02 10-K Annual Report – 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2021-02-24 126,469 664,900 19.02
2021-02-23 234,851 1,364,100 17.22
2021-02-22 125,575 780,000 16.10

(click for more detail)

(click for list of largest short owners)

Similar Companies
DMTK – DermTech, Inc. FLGT – Fulgent Genetics, Inc.
FMI – Foundation Medicine, Inc. GHDX – Genomic Health, Inc.
NTRA – Natera, Inc.


Financial data and stock pages provided by
Fintel.io